| 11345725 |
Bis-thioether stapled peptides as inhibitors of PRC2 function |
Guillermo Gerona-Navarro, Flavia Barragan |
2022-05-31 |
|
| 11339150 |
Benzimidazole compounds as HDAC6 inhibitors |
Anthony D. Piscopio, Kevin W. Hunt |
2022-05-24 |
|
| 11267818 |
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds |
Julia Haas, Steven W. Andrews, Yutong Jiang |
2022-03-08 |
|
| 10774085 |
Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds |
Julia Haas, Steven W. Andrews, Yutong Jiang |
2020-09-15 |
|
| 10590139 |
Method of treatment using substituted imidazo[1,2b]pyridazine compounds |
Steven W. Andrews, Julia Haas, Yutong Jiang |
2020-03-17 |
|
| 10508122 |
Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof |
Xuedong Liu, Daniel Chuen-Fong Chan, Anthony D. Piscopio |
2019-12-17 |
|
| RE47690 |
Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof |
Xuedong Liu, Daniel Chuen-Fong Chan, Anthony D. Piscopio |
2019-11-05 |
|
| 10259846 |
Bouvardin derivatives and therapeutic uses thereof |
Tin Tin Su, Mara N. Gladstone, Tarek Sammakia |
2019-04-16 |
|
| 10047097 |
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds |
Julia Haas, Steven W. Andrews, Yutong Jiang |
2018-08-14 |
$35,978,000 |
| 10011604 |
Method of treatment using substituted imidazo[1,2b]pyridazine compounds |
Steven W. Andrews, Julia Haas, Yutong Jiang |
2018-07-03 |
$45,694,000 |
| 10005783 |
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds |
Julia Haas, Steven W. Andrews, Yutong Jiang |
2018-06-26 |
$22,336,000 |
| 9840520 |
Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof |
Xuedong Liu, Daniel Chuen-Fong Chan, Anthony D. Piscopio |
2017-12-12 |
|
| 9795611 |
Method of treatment using substituted imidazo[1,2b]pyridazine compounds |
Steven W. Andrews, Julia Haas, Yutong Jiang |
2017-10-24 |
$9,622,000 |
| 9796723 |
Method of treatment using substituted imidazo[1,2b]pyridazine compounds |
Steven W. Andrews, Julia Haas, Yutong Jiang |
2017-10-24 |
$9,622,000 |
| 9676783 |
Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds |
Julia Haas, Steven W. Andrews, Yutong Jiang |
2017-06-13 |
$10,834,000 |
| 9452215 |
Bourvadin derivatives and therapeutic uses thereof |
Tin Tin Su, Mara N. Gladstone, Tarek Sammakia |
2016-09-27 |
|
| 9447104 |
Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds |
Julia Haas, Steven W. Andrews, Yutong Jiang |
2016-09-20 |
$7,414,000 |
| 9422340 |
Macrocyclic compounds useful as inhibitors of histone deacetylases |
Xuedong Liu, Andrew J. Phillips, Dana Ungermannova, Christopher G. Nasveschuk |
2016-08-23 |
|
| 9227975 |
Method of treatment using substituted imidazo[1,2B]pyridazine compounds |
Steven W. Andrews, Julia Haas, Yutong Jiang |
2016-01-05 |
$8,559,000 |
| 9127013 |
Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds |
Julia Haas, Steven W. Andrews, Yutong Jiang |
2015-09-08 |
$6,159,000 |
| 8865698 |
Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds |
Julia Haas, Steven W. Andrews, Yutong Jiang |
2014-10-21 |
$2,720,000 |
| 8754050 |
Macrocyclic compounds useful as inhibitors of histone deacetylases |
Xuedong Liu, Andrew J. Phillips, Dana Ungermannova, Christopher G. Nasveschuk |
2014-06-17 |
|
| 8513263 |
Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors |
Julia Haas, Steven W. Andrews, Yutong Jiang |
2013-08-20 |
$4,403,000 |
| 8450322 |
Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitors |
Steven ANDREWS, Julia Haas, Yutong Jiang |
2013-05-28 |
$9,040,000 |
| 7179813 |
Bicyclic indolyl derivatives and methods for their use as serotonergic agents |
Michael G. Kelly, Wayne E. Childers, Boyd L. Harrison, Byron A. Bravo, Lee Schechter |
2007-02-20 |
$40,010,000 |
